Your SlideShare is downloading. ×
Case control studies..skp
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Case control studies..skp

1,840
views

Published on

Published in: Health & Medicine, Business

0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
1,840
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
117
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. DR. Sudhira Kumar Parida.
  • 2. OVERVIEW Introduction. Design of a Case-Control Study. Hallmark. Selection of cases. Selection of controls. Problems in control selection. Multiple control. Matching. When warranted? Case-Control Study based in a defined cohort. Measurement of exposure. Analysis & Interpretation. Bias Adv & disadv. Examples
  • 3. INTRODUCTION Epidemiological Studies Observational studies  Experimental studiesA.Descriptive studies A.RCT/ Clinical trialsB.Analytical studies B.Field trials/ Community 1.Ecological/ intervention studies Correlational C.Community trials. 2.Cross-sectional/ Prevalence 3.Case-control/ Case- reference 4.Cohort/ Follow-up
  • 4. DESIGN OF A CASE-CONTROLSTUDY First Select CASES CONTROLS (with disease) (without ds)THEN MEASURE PAST EXPOSURE Were Exposed a b Were Not exposed c d Total a+c b+d Proportions Exposed a b a+c b+d
  • 5. HALLMARK It begins with people with the disease(CASES) & COMPARES them to people without the ds(CONTROLS).
  • 6. SELECTION OF CASES Definition of a CASE: i)diagnostic criteria & stage of the ds ,if any. ii)eligibility criteria-preferably incident cases. Sources: 1.hospital-based 2.population-based Case verification Exclusion criteria
  • 7. SELECTION OF CONTROLS Who is a CONTROL Sources:1.hospital-based2.population-based i)school rosters ii)selective service lists iii)insurance company lists iv)neighbourhood v)best friend vi)spouse/ sibling vii)dead
  • 8. USE OF MULTIPLE CONTROLS Same types: -increases the power of the study(only upto 1case:4control) Different types: -for exploring alternate hypotheses -for taking account possible potential biases like recall bias.
  • 9. MATCHING Def: The process of selecting the controls so that they are similar to cases in certain characteristics ,such as age,race,sex,socio-eco. status & occupation. Types: 1.Group/ Frequency 2.Individual/ Matched pairs. Problems: a)practical-difficulty in finding a control b)conceptual-cannot study that characteristic c)unplanned matching d)overmatching
  • 10. WHEN A CASE-CONTROL STUDYIS WARRANTED Often the 1st step in determining whether an exposure is linked to an increased risk of ds. Rare ds.
  • 11. CASE-CONTROL STUDIES BASED INA DEFINED COHORT Defined Initial Data &/or Sr.,Urine or Cohort Other specimens YEARS Develop Disease Have Not developed disease Sub-gr CASES selected as CONTROL
  • 12.  Nested Case-Control Studies: -controls are a sample of individuals who are at risk for the ds at the time of each case of the ds develops. -cases & controls are matched on calendar time & length of follow-up. Case-Cohort Studies: -controls are randomly chosen. -Adv: possible to study different diseases.
  • 13. ADVANTAGES OF EMBEDDING ACASE-CONTROL STUDY IN ADEFINED COHORT Recall bias-eliminated. Abnormalities in biologic characteristics like lab values –risk factors. More economical. Less lab burden. Greater comparability b/w cases & controls.
  • 14. MEASUREMENT OF EXPOSURE( IN PRICESLY THE SAME MANNER BOTH FOR CASES & CONTROLS .) Interviews Questionnaires Past records of cases -hospital records -employment records etc.
  • 15. ANALYSIS Exposure rates among cases & controls to suspected factor. Estimation of ds risk asso. With exposure( ODDS RATIO).
  • 16. EXPOSURE RATES: Direct estimation. A Case-Control Study of Smoking &Lung cancer. Cases Controls (with Lung cancer) (without lung cancer)Smokers(<5 cigarettes/d) 33 (a) 55 (b)Non-smokers 2 (c) 27 (d)Total 35 (a+c) 82 (b+d) Exposure rates: . Cases= a/a+c= 33/35 =94.2% . Controls= b/b+d =55/82 =67%.
  • 17. ODDS RATIO(RELATIVE ODDS/ CROSS-PRODUCTS RATIO.) A measure of the Strength of the association b/w risk factor & ds. Def: OR= Odds that a case was exposed Odds that a control was exposed = a/c = b/d ad bc = Product of 2 cells that SUPPORT the hypothesis Product of 2 cells that NEGATE the hypothesis
  • 18.  Interpretation: OR=1 (exposure is not related to the ds) >1 (+ly related) <1 (- ly related). OR is a good approximation of RR when: -cases studied are representative of those with the ds. -controls studied are representative of those without the ds. -ds being studied does not occur frequently.
  • 19.  CALCULATING ‘OR’ IN AN UNMATCHED CASE- CONTROL STUDY: OR= ad bc CALCULATING ‘OR’ IN A MATCHED PAIRS CASE- CONTROL STUDY: CONTROL Exposed Not exposed C Exposed p q A S Not exposed r s E OR=Ratio of discordant pairs=q/r.
  • 20. BIAS Bias due to confounding. Recall bias. Selection bias. Berkesonian bias. Interviewer’s bias.
  • 21. ADVANTAGES Relatively easy. Rapid & inexpensive. Rare ds. No risk to subjects. Allows study of several different aetiological factors. Risk factors can be identified----- rational prevention & control programme No attrition problems. Minimal ethical problem.
  • 22. DISVANTAGES Recall bias. Selection of appropriate control gr. –may be difficult. Cannot measure incidence. Cannot distinguish b/w causes & asso. Factors. Not suited to evaluation of Tt/ Px of ds. Concern about representativeness of cases & controls.
  • 23. EXAMPLES MATERNAL DES THERAPY & ADENOCARCINOMA OF VAGINA IN FEMALE OFFSPRINGS: CASES CONTROLS SIGNIFICANCE (8) (32) LEVELMaternal age 26.1 29.3 n.s.Maternal smoking 7 21 n.s.Antenatal radiology 1 4 n.s.Oestrogen exposure 7 -- P< 0.00001
  • 24. OCP & THROMBOEMBOLIC DISEASE: CASES(Venous CONTROLS thrombosis & pul.embolism) (84) (168)% who used OCP 50 14THALIDOMIDE TRAGEDY: CASES(46) CONTROLS(300)Thalidomide exposure in 41 --early pregnancy
  • 25. REFERENCES Leon Gordis,4th ed. Silman, Macfarane ,2nd ed. Park,20th ed.
  • 26. THANK YOU.